TAP Pharmaceutical Products, Inc.
TAP Pharmaceutical Products, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 1970, the company has established itself as a leader in the development and marketing of innovative therapies, particularly in the fields of urology and oncology. TAP is renowned for its flagship product, Lupron, which has transformed the treatment landscape for prostate cancer and other hormone-related conditions.
With a strong presence across North America and significant operations in various global markets, TAP Pharmaceutical Products has achieved notable milestones, including strategic partnerships that enhance its research capabilities. The company is committed to advancing patient care through its unique offerings, which combine cutting-edge science with a patient-centric approach. TAP's dedication to quality and innovation solidifies its position as a trusted name in the pharmaceutical sector.
+38 vs industry average
TAP Pharmaceutical Products, Inc.’s score of 76 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at TAP Pharmaceutical Products, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for TAP Pharmaceutical Products, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
TAP Pharmaceutical Products, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for TAP Pharmaceutical Products, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Takeda Pharmaceutical Company Limited
Carbon Disclosure Project
Inherited from Takeda Pharmaceutical Company LimitedThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Takeda Pharmaceutical Company LimitedRE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project